Annual CAPEX
$74.25 M
-$46.37 M-38.44%
December 31, 2024
Summary
- As of March 1, 2025, PTCT annual capital expenditures is $74.25 million, with the most recent change of -$46.37 million (-38.44%) on December 31, 2024.
- During the last 3 years, PTCT annual CAPEX has fallen by -$11.08 million (-12.99%).
- PTCT annual CAPEX is now -51.30% below its all-time high of $152.46 million, reached on December 31, 2022.
Performance
PTCT CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CAPEX
$6.50 M
-$4.28 M-39.71%
December 31, 2024
Summary
- As of March 1, 2025, PTCT quarterly capital expenditures is $6.50 million, with the most recent change of -$4.28 million (-39.71%) on December 31, 2024.
- Over the past year, PTCT quarterly CAPEX has dropped by -$57.85 million (-89.90%).
- PTCT quarterly CAPEX is now -92.02% below its all-time high of $81.45 million, reached on March 31, 2022.
Performance
PTCT Quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CAPEX
$74.25 M
-$21.96 M-22.83%
December 31, 2024
Summary
- As of March 1, 2025, PTCT TTM capital expenditures is $74.25 million, with the most recent change of -$21.96 million (-22.83%) on December 31, 2024.
- Over the past year, PTCT TTM CAPEX has dropped by -$67.05 million (-47.45%).
- PTCT TTM CAPEX is now -51.30% below its all-time high of $152.46 million, reached on December 31, 2022.
Performance
PTCT TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
PTCT CAPEX Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -38.4% | -89.9% | -47.5% |
| 3 y3 years | -13.0% | -77.8% | -37.7% |
| 5 y5 years | +63.4% | -77.8% | -37.7% |
PTCT CAPEX Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -51.3% | at low | -92.0% | +188.1% | -51.3% | at low |
| 5 y | 5-year | -51.3% | +63.4% | -92.0% | +188.1% | -51.3% | +89.3% |
| alltime | all time | -51.3% | >+9999.0% | -92.0% | +188.1% | -51.3% | >+9999.0% |
PTC Therapeutics CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $74.25 M(-38.4%) | $6.50 M(-39.7%) | $74.25 M(-22.8%) |
| Sep 2024 | - | $10.78 M(-246.1%) | $96.21 M(-16.1%) |
| Jun 2024 | - | -$7.38 M(-111.5%) | $114.64 M(-18.9%) |
| Mar 2024 | - | $64.35 M(+126.1%) | $141.30 M(+17.1%) |
| Dec 2023 | $120.62 M(-20.9%) | $28.46 M(-2.5%) | $120.62 M(+1.2%) |
| Sep 2023 | - | $29.21 M(+51.5%) | $119.15 M(+2.7%) |
| Jun 2023 | - | $19.28 M(-55.8%) | $115.97 M(+1.1%) |
| Mar 2023 | - | $43.67 M(+61.7%) | $114.68 M(-24.8%) |
| Dec 2022 | $152.46 M(+78.7%) | $27.00 M(+3.7%) | $152.46 M(+2.0%) |
| Sep 2022 | - | $26.02 M(+44.6%) | $149.50 M(+0.1%) |
| Jun 2022 | - | $17.99 M(-77.9%) | $149.29 M(+1.6%) |
| Mar 2022 | - | $81.45 M(+238.8%) | $146.92 M(+72.2%) |
| Dec 2021 | $85.33 M(+52.4%) | $24.04 M(-6.9%) | $85.33 M(+6.4%) |
| Sep 2021 | - | $25.81 M(+65.2%) | $80.16 M(-0.9%) |
| Jun 2021 | - | $15.62 M(-21.4%) | $80.85 M(+38.5%) |
| Mar 2021 | - | $19.86 M(+5.3%) | $58.38 M(+4.3%) |
| Dec 2020 | $55.98 M(+23.2%) | $18.87 M(-28.8%) | $55.98 M(+5.2%) |
| Sep 2020 | - | $26.50 M(-486.8%) | $53.19 M(+35.7%) |
| Jun 2020 | - | -$6.85 M(-139.3%) | $39.21 M(-34.7%) |
| Mar 2020 | - | $17.46 M(+8.5%) | $60.03 M(+32.1%) |
| Dec 2019 | $45.44 M(+192.6%) | $16.09 M(+28.5%) | $45.44 M(+18.0%) |
| Sep 2019 | - | $12.52 M(-10.3%) | $38.49 M(+23.5%) |
| Jun 2019 | - | $13.97 M(+387.5%) | $31.18 M(+74.0%) |
| Mar 2019 | - | $2.87 M(-68.6%) | $17.92 M(+15.4%) |
| Dec 2018 | $15.53 M | $9.14 M(+75.6%) | $15.53 M(+84.1%) |
| Sep 2018 | - | $5.21 M(+635.2%) | $8.44 M(-89.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2018 | - | $708.00 K(+47.8%) | $80.87 M(+0.4%) |
| Mar 2018 | - | $479.00 K(-76.6%) | $80.52 M(+0.3%) |
| Dec 2017 | $80.26 M(+4419.4%) | $2.04 M(-97.4%) | $80.26 M(+1.0%) |
| Sep 2017 | - | $77.64 M(>+9900.0%) | $79.46 M(+3720.0%) |
| Jun 2017 | - | $354.00 K(+57.3%) | $2.08 M(+19.8%) |
| Mar 2017 | - | $225.00 K(-81.8%) | $1.74 M(-2.3%) |
| Dec 2016 | $1.78 M(-34.7%) | $1.24 M(+366.4%) | $1.78 M(+18.7%) |
| Sep 2016 | - | $265.00 K(+2550.0%) | $1.50 M(-17.7%) |
| Jun 2016 | - | $10.00 K(-96.2%) | $1.82 M(-13.5%) |
| Mar 2016 | - | $265.00 K(-72.3%) | $2.10 M(-22.7%) |
| Dec 2015 | $2.72 M(-41.7%) | $956.00 K(+62.9%) | $2.72 M(-48.4%) |
| Sep 2015 | - | $587.00 K(+99.7%) | $5.27 M(+5.4%) |
| Jun 2015 | - | $294.00 K(-66.7%) | $5.00 M(-6.7%) |
| Mar 2015 | - | $883.00 K(-74.8%) | $5.36 M(+14.9%) |
| Dec 2014 | $4.66 M(+451.3%) | $3.51 M(+999.7%) | $4.66 M(+205.2%) |
| Sep 2014 | - | $319.00 K(-51.0%) | $1.53 M(-3.7%) |
| Jun 2014 | - | $651.00 K(+250.0%) | $1.59 M(+57.0%) |
| Mar 2014 | - | $186.00 K(-50.0%) | $1.01 M(+19.5%) |
| Dec 2013 | $846.00 K(+347.6%) | $372.00 K(-1.6%) | $846.00 K(+76.4%) |
| Sep 2013 | - | $378.00 K(+404.0%) | $479.50 K(+353.2%) |
| Jun 2013 | - | $75.00 K(+257.1%) | $105.80 K(+105.0%) |
| Mar 2013 | - | $21.00 K(+281.8%) | $51.60 K(-72.7%) |
| Dec 2012 | $189.00 K(+14.5%) | $5500.00(+27.9%) | $189.00 K(+3.0%) |
| Sep 2012 | - | $4300.00(-79.3%) | $183.50 K(+2.4%) |
| Jun 2012 | - | $20.80 K(-86.9%) | $179.20 K(+13.1%) |
| Mar 2012 | - | $158.40 K | $158.40 K |
| Dec 2011 | $165.10 K | - | - |
FAQ
- What is PTC Therapeutics annual capital expenditures?
- What is the all time high annual CAPEX for PTC Therapeutics?
- What is PTC Therapeutics annual CAPEX year-on-year change?
- What is PTC Therapeutics quarterly capital expenditures?
- What is the all time high quarterly CAPEX for PTC Therapeutics?
- What is PTC Therapeutics quarterly CAPEX year-on-year change?
- What is PTC Therapeutics TTM capital expenditures?
- What is the all time high TTM CAPEX for PTC Therapeutics?
- What is PTC Therapeutics TTM CAPEX year-on-year change?
What is PTC Therapeutics annual capital expenditures?
The current annual CAPEX of PTCT is $74.25 M
What is the all time high annual CAPEX for PTC Therapeutics?
PTC Therapeutics all-time high annual capital expenditures is $152.46 M
What is PTC Therapeutics annual CAPEX year-on-year change?
Over the past year, PTCT annual capital expenditures has changed by -$46.37 M (-38.44%)
What is PTC Therapeutics quarterly capital expenditures?
The current quarterly CAPEX of PTCT is $6.50 M
What is the all time high quarterly CAPEX for PTC Therapeutics?
PTC Therapeutics all-time high quarterly capital expenditures is $81.45 M
What is PTC Therapeutics quarterly CAPEX year-on-year change?
Over the past year, PTCT quarterly capital expenditures has changed by -$57.85 M (-89.90%)
What is PTC Therapeutics TTM capital expenditures?
The current TTM CAPEX of PTCT is $74.25 M
What is the all time high TTM CAPEX for PTC Therapeutics?
PTC Therapeutics all-time high TTM capital expenditures is $152.46 M
What is PTC Therapeutics TTM CAPEX year-on-year change?
Over the past year, PTCT TTM capital expenditures has changed by -$67.05 M (-47.45%)